| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/25/2007 | CA2306257C 5-azaquinoxaline-based compounds and modulation of serine/threonine protein kinase function |
| 09/25/2007 | CA2305468C 8-azabicyclo [3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 09/25/2007 | CA2301183C Pharmacologic drug combination in vagal-induced asystole |
| 09/25/2007 | CA2294278C Chalcones having antiproliferative activity |
| 09/25/2007 | CA2269815C Thienopyrimidines having pde v-inhibiting action |
| 09/25/2007 | CA2243317C Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 09/25/2007 | CA2192442C Complementary adenoviral vector systems and cell lines |
| 09/20/2007 | WO2007106049A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| 09/20/2007 | WO2007105823A1 Prophylactic/therapeutic agent for alzheimer's disease |
| 09/20/2007 | WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | WO2007105753A1 Triazole derivative or salt thereof |
| 09/20/2007 | WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | WO2007105706A1 Skin-whitening agent for external application to the skin, and method for whitening the skin |
| 09/20/2007 | WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | WO2007105551A1 Novel pyridine derivative having anti-helicobacter pylori activity |
| 09/20/2007 | WO2007105353A1 Plant-derived therapeutic agent for malignant tumor |
| 09/20/2007 | WO2007105199A1 Use of caspases for the preparation of medicaments |
| 09/20/2007 | WO2007104933A1 Chemical compounds |
| 09/20/2007 | WO2007104242A1 Compounds capable of inhibiting zinc ion metalloproteinases |
| 09/20/2007 | WO2007066041A3 Skin depigmentation composition containing a naphthonic acid derivative |
| 09/20/2007 | WO2007036743A3 Quinolines and their therapeutic use |
| 09/20/2007 | WO2002000649A9 Substituted quinazoline derivatives and their use as inhibitors |
| 09/20/2007 | US20070219356 Controlling cell proliferation, cell differentiation; immobilization; prelude to bone marrow transplants; stability, solubility, enhanced circulating half-life and plasma residence times |
| 09/20/2007 | US20070219255 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219232 Chemical Compounds |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070219194 Phenylalanine derivatives |
| 09/20/2007 | US20070219180 Muscle Relaxtion Accelerator and Therapeutic Agent for Muscular Tissue Diseases Such as Muscle Relaxation Failure |
| 09/20/2007 | US20070219179 Indole Derivative Having Piperidine Ring |
| 09/20/2007 | US20070219177 Agent for treatment of cerebral ischemic diseases |
| 09/20/2007 | US20070219150 Nerve Cell Differentiation Inducer |
| 09/20/2007 | US20070219136 Methods and compositions for treating inflammatory disorders |
| 09/20/2007 | US20070219130 Administering an effective amount of a SLURP-1 polypeptide of SEQ ID NO: 2; analegsics; neuregulins, promoting the the amplitude of acetylcholine-evoked macroscopic currents; nervous system disorders; neuroprotectants; skindisorders |
| 09/20/2007 | US20070218523 Modified human thymic stromal lymphopoietin |
| 09/20/2007 | US20070218147 Peroxisome Proliferator-Activated Receptor (Ppar) Activator, and Drugs, Supplements, Functional Foods and Food Additives Using the Same |
| 09/20/2007 | US20070218121 Compounds that inhibit caspase activity for treating glaucoma |
| 09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
| 09/20/2007 | US20070218076 Method of Processing Seaweed |
| 09/20/2007 | US20070218041 Topical composition having undifferentiated plant seed cells and method for using same |
| 09/20/2007 | US20070218037 Therapeutic agent for fibromyalgia |
| 09/20/2007 | US20070218026 DNA encoding the human serine protease EOS |
| 09/20/2007 | US20070218003 Truncated Dance, Dance Complex And Method Of Using These |
| 09/20/2007 | DE20321512U1 Zusammensetzung zur Erleichterung der Humangeburt Composition to facilitate human childbirth |
| 09/20/2007 | CA2646240A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| 09/20/2007 | CA2645712A1 Triazole derivative or salt thereof |
| 09/20/2007 | CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | CA2645676A1 Use of caspases for the preparation of medicaments |
| 09/20/2007 | CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/19/2007 | EP1835030A1 OB fusion protein compositions and methods |
| 09/19/2007 | EP1835027A1 Novel cancer antigen peptide and the use thereof |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1834959A2 Tert-butyl-substituted aromatic steroids having cytoprotective activity |
| 09/19/2007 | EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 09/19/2007 | EP1834670A2 Anthelmintic compositions containing combinations of avermectins or milbemycins with bis-aryl compounds |
| 09/19/2007 | EP1834646A1 Ultrasonic cancer therapy accelerator and cytotoxic agent |
| 09/19/2007 | EP1834639A1 Remedial agent for fat toxicity |
| 09/19/2007 | EP1834628A1 Cosmetic composition comprising phytosterols, isoflavones and methylricinoleate, use as inhibitor of 5-alpha-reductase and hair growth |
| 09/19/2007 | EP1799641A4 Process for the preparation of amorphous fluvastatin sodium |
| 09/19/2007 | EP1515975B1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/19/2007 | EP1511719B1 Amide derivatives as inhibitors of the enzymatic activity of renin |
| 09/19/2007 | EP1499605B1 NF-KappaB INHIBITORS |
| 09/19/2007 | EP1496907B1 Tyrosine kinase inhibitors |
| 09/19/2007 | EP1490335B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/19/2007 | EP1480976B1 Thiazole derivatives as npy receptor antagonists |
| 09/19/2007 | EP1474396B1 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/19/2007 | EP1471974B1 Tumor necrosis factor combined with interferon in demyelinating diseases |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | EP1407044B1 Rna interference mediating small rna molecules |
| 09/19/2007 | EP1309590B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 09/19/2007 | EP1296982B1 1-(heteroaryl-phenyl)-condensed pyrazol derivatives as factor xa inhibitors |
| 09/19/2007 | EP1255844B1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 09/19/2007 | EP1190071B1 17867, a novel human aminopeptidase |
| 09/19/2007 | EP1141003B1 Methods of activation of SGK by phosphorylation. |
| 09/19/2007 | EP0977767B1 Aminooxy-modified oligonucleotides |
| 09/19/2007 | CN101039953A Therapeutic and diagnostic agents |
| 09/19/2007 | CN101039934A 1,5-diheterocycle-1H-triazole derivative |
| 09/19/2007 | CN101039927A Serotonin 5-HT3 receptor agonist |
| 09/19/2007 | CN101039678A Imidazo[1,5a]triazolo[1,5d]benzodiazepine derivatives for the treatment of cognitive disorders |
| 09/19/2007 | CN101039663A STAT3 phosphorylation inhibitor and notch 1 expression inhibitor |
| 09/19/2007 | CN101037438A Compositions useful as inhibitors of GSK-3 |
| 09/19/2007 | CN101036722A Health-caring food for easing and improving climacteric Syndrome of men and the preparation thereof |
| 09/19/2007 | CN101036494A Technique of producing aweto teabag |
| 09/19/2007 | CN101036452A Relaxation method for nucleated pearl after an operation |
| 09/19/2007 | CN100338219C Tissue specific expression of retinoblastoma protein |
| 09/19/2007 | CN100338086C Immunostimulatory nucleic acid molecules |
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/19/2007 | CN100338066C Hexacyclic compounds |
| 09/19/2007 | CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 09/19/2007 | CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors |
| 09/19/2007 | CN100338058C 新的吲哚衍生物 The new indole derivatives |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100338041C Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 09/19/2007 | CN100338040C Xanthine oxidase inhibitors |
| 09/19/2007 | CN100338036C Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes |
| 09/19/2007 | CN100338028C Crystalline forms of venlafaxine hydrochloride |
| 09/19/2007 | CN100337666C Preparation method of compound peach blossom deea tortoise life nourishing agent |
| 09/19/2007 | CN100337632C Endothelin antagonist |
| 09/19/2007 | CN100337620C Water-soluble composition containing coenzyme q10 |